SPONSOR
Sun Yat-Sen University Cancer Center
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Conditions studied: NeuroblastomaMultiple Brain Metastases in Lung AdenocarcinomaTriple Negative Breast Cancer
NCT06013618 Phase 2
Recruiting
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Neuroblastoma
NCT07058428 Phase 3
Recruiting
FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma
Multiple Brain Metastases in Lung Adenocarcinoma
NCT04722978 Phase 3
Recruiting
Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Triple Negative Breast Cancer